ClinicalTrials.gg
CompletedNCT01594086Updated Jul 16, 2013

Effects of Green Tea Consumption on Homocysteine Metabolism and Cognitive Dysfunction

An interventional study of green tea powder in Cognitive Impairment, sponsored by University of Shizuoka. Completed at 1 site in Japan. Open to participants aged 50 Years to 95 Years. Per ClinicalTrials.gov, last updated 2013-07-16.

Sponsored by University of Shizuoka · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
50 Years to 95 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Cognitive Dysfunction with a site in Japan — 4 open to participants now, 9 under way, 6 of them phase 3. Cognitive Dysfunction · Japan.

Planned enrollment
26th of 26
15 · median 378
Started
2012
with 2 others
No phase
2 of 28
none open now
Registered
6th of 28
by date

Among the 28 studies in Cognitive Dysfunction with a site in Japan, this one is the 26th largest by planned enrollment of the 26 interventional ones that give a count, is one of 3 that started in 2012, is one of 2 with no phase, and was the 6th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

4 of the 28 studies in Cognitive Dysfunction with a site in Japan are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 50 Years to 95 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Cognitive Dysfunction with a site in Japan, or all of them as a file.
02

Study summary

Green tea contains catechins and theanine as major ingredients and has been reported to have various beneficial influences on human health. It is reported that the drinking green tea is inversely associated with serum homocysteine level in elderly. However the effect of green tea consumption on cognitive dysfunction is not clinically clarified. The purpose of this study is to investigate the effects of green tea consumption on homocysteine metabolism and cognitive dysfunction in elderly with impaired cognitive function.

Read the detailed description

Elderly people with impaired cognitive function go on increasing year by year with the coming aged society. Among them, the Alzheimer disease is a major cause of the illness, which is progressively worse, has no fundamental curable therapy, and induces the burdens of caregivers as well as the health insurance and national budget. Recently, homocysteine metabolism is reported to be related to atherosclerosis in aging, and draw attention as the etiology of cognitive dysfunction in elderly.

Green tea contains catechins and theanine as main ingredients. These components are reported to have anti-atherogenic action and effect on improving cognitive dysfunction. However, clinical evidence for homocysteine metabolism and cognitive dysfunction has not been clarified. Therefore, in this study, the investigators attempted to investigate the effects of green tea consumption on homocysteine metabolism and cognitive dysfunction in elderly with impaired cognitive function.

03

Conditions studied

  • Cognitive Impairment

Keywords

  • green tea
  • aging
  • atherosclerosis
  • homocysteine
  • cognitive impairment
04

Who can participate

Ages eligible
50 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Obtained written before participation
  • Possible to consume green tea powder
  • Possessing cognitive dysfunction; score less than 30
  • Possible not to take any supplement possessing anti-oxidizing effect; i.e., vitamin A, C, E, β-carotene

Exclusion criteria

Exclusion Criteria:

  • Possessing allergy to green tea
  • Possessing severe cardiac, respiratory, renal, or hepatic dysfunction
  • Possessing severe anemia
  • Diagnosed as inadequate to participate in the study by doctor
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    green tea powder

    Natural green tea powder

    Dietary Supplement: green tea powder

Interventions

  • Dietary supplementTeaStudies of TeaTea pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Consuming 2 g/day of green tea powder in three times divided for 3 months

06

What researchers measure

Primary outcomes

  1. Changes in the serum homocysteine levels

    Changes in the serum homocysteine levels before and after the intervention

    Time frame: between baseline and 3 months after

Secondary outcomes

  1. Changes in serum lipid levels

    Changes in serum lipid levels before and after the intervention

    Time frame: between baseline and 3 months after

  2. Changes in serum folic acid levels

    Changes in serum folic acid levels before and after the intervention

    Time frame: between baseline and 3 months after

  3. Changes in mini mental state examination (MMSE) scores

    Changes in mini mental state examination (MMSE) scores before and after the intervention

    Time frame: between baseline and 3 months after

07

Study locations

1 site
  • White Cross Nursing Home
    Higashimurayama, Tokyo 189-0021, Japan
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2012, a primary completion of Jul 2013 and a completion of Jul 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 1, 2012
First posted
May 8, 2012
Start
May 2012
Primary completionActual
Jul 2013
CompletionActual
Jul 2013
Last update
Jul 16, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01594086
Lead sponsor
University of Shizuoka
Responsible party
Sponsor
First posted
May 8, 2012
Start date
May 2012
Primary completion
Jul 2013
Completion
Jul 2013
Last update
Jul 16, 2013

Study contacts

Yamada, Hiroshi
study chair · University of Shizuoka

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tea

Start the discussion